Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	38.02	-130.79	-211.02
Graham Fair Price	35.70	6.52	4.81
PEG	-81.70	-0.67	3.65
Price/Book	-23.14	5.61	7.30
Price/Cash Flow	29.91	-200.80	-286.50
Prices/Earnings	54.24	-55.66	-121.63
Price/Sales	inf	0.00	183313.52
Price/FCF	29.91	-200.80	-286.50
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	inf	0.00	0.83
Operating Margin	inf	0.00	-761.42
ROA	-71.61	-0.02	-0.01
ROE	-0.02	-0.03	-67.97
ROIC	-0.03	-0.04	-20.50
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	20.83	-99.95
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.16	-0.32	-101.61
EPS QOQ	0.33	-0.83	150.00
FCF QOQ	-0.37	-0.20	45.12
Revenue QOQ	0.00	-1.00	-100.00
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	4819.01	0.00	inf
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	< 0.005	< 0.005	-9.46
Quick Ratio	51.38	61.56	19.81
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	8.27	8.66	4.70
Cash	8.53	8.73	2.40
Capex	< 0.005	< 0.005	28.83
Free Cash Flow	-0.21	-0.24	-14.82
Revenue	< 0.005	0.00	inf
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	51.59	62.13	20.42
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	29.78	22.97	-22.86
Naive Interpretation	Member

06 - Financial Health · Bad

Rating